Genentech Sues Apotex Over Generic Valcyte

Law360, San Francisco (May 19, 2011, 6:21 PM EDT) -- Roche Holding Ltd. subsidiary Genentech Inc. sued Apotex Inc. in California on Tuesday, accusing it of infringing a patent covering the anti-viral drug Valcyte.

Genentech and Roche Palo Alto LLC's complaint claims Apotex infringed U.S. Patent Number 6,083,953 by seeking U.S. Food and Drug Administration approval for a generic version of Valcyte, and seeks to block the Canadian drugmaker from selling its product in the U.S. before that patent expires.

“Apotex threatens to market and sell the Apotex generic product in California and elsewhere in the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.